Since RAC1 has been shown to play a major role in cytoskeleton assembly, tumorigenesis and tumor proliferation, we thus hypothesized that DOCK1 deficiency sensitizes cancer cells to metformin via inhibition of RAC1 activation. The gene discussed is DOCK1; the disease is cancer.